This Article Full Text Full Text (PDF) All Versions of this Article: 40/5/748    most recent 01.HYP.0000035522.63647.D3v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goetze, S. Articles by Gräfe, M. Search for Related Content PubMed PubMed Citation Articles by Goetze, S. Articles by Gräfe, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Cardiovascular Pharmacology Angiogenesis Cell signalling/signal transduction Mechanism of atherosclerosis/growth factors

(Hypertension. 2002;40:748.)
© 2002 American Heart Association, Inc.

Scientific Contributions

Leptin Induces Endothelial Cell Migration Through Akt, Which Is Inhibited by PPAR-Ligands

Stephan Goetze; Anne Bungenstock; Cornelia Czupalla; Friedrich Eilers; Philipp Stawowy; Ulrich Kintscher; Chantel Spencer-Hänsch; Kristof Graf; Bernd Nürnberg; Ronald E. Law; Eckart Fleck; Michael Gräfe

From the Department of Medicine/Cardiology, German Heart Institute Berlin (S.G., A.B., F.E., P.S., U.K., C.S.-H., K.G., E.F., M.G.); Department of Pharmacology, Free University Berlin (C.C., B.N.); Institut für Physiologische Chemie II, Universität Düsseldorf, Germany (C.C., B.N.); and Division of Endocrinology, Diabetes, and Hypertension, University of California Los Angeles School of Medicine (R.E.L.), Los Angeles, Calif.

Correspondence to Stephan Goetze, MD, Cardiology Fellow at the Department of Medicine/Cardiology, German Heart Institute Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail goetze{at}dhzb.de

Migration of endothelial cells (EC) is a key event in angiogenesis that contributes to neovascularization in diabetic vasculopathy. Leptin induces angiogenesis and is elevated in obesity and hyperinsulinemia. The antidiabetic thiazolidinediones (TZD) inhibit leptin gene expression and vascular smooth muscle cell migration through activation of the peroxisome proliferator–activated receptor- (PPAR). This study investigates the role of leptin in EC migration, the chemotactic signaling pathways involved, and the effects of the TZD-PPAR ligands troglitazone (TRO) and ciglitazone (CIG) on EC migration. We demonstrate that leptin induces EC migration. Because activation of two signaling pathways, the phosphatidylinositol-3 kinase (PI3K)AkteNOS and the ERK1/2 MAPK pathway, is known to be involved in cell migration, we used the pharmacological inhibitors wortmannin and PD98059 to determine if chemotactic signaling by leptin involves Akt or ERK1/2, respectively. Both wortmannin and PD98059 significantly inhibited leptin-induced migration. Treatment with the TZD-PPAR-ligands TRO and CIG significantly inhibited the chemotactic response toward leptin. Both PPAR-ligands inhibited leptin-stimulated Akt and eNOS phosphorylation, but neither attenuated ERK 1/2 activation in response to leptin. The inhibition of Akt-phosphorylation was accompanied by a PPAR-ligand–mediated upregulation of PTEN, a phosphatase that functions as a negative regulator of PI3KAkt signaling. These experiments provide the first evidence that activation of Akt and ERK 1/2 are crucial events in leptin-mediated signal transduction leading to EC migration. Moreover, inhibition of leptin-directed migration by the PPAR-ligands TRO and CIG through inhibition of Akt underscores their potential in the prevention of diabetes-associated complications.

Key Words: signal transduction • endothelium • kinase • diabetes mellitus • vasculature • phosphorylation

This article has been cited by other articles:

				K. Wu, S. Katiyar, A. Li, M. Liu, X. Ju, V. M. Popov, X. Jiao, M. P. Lisanti, A. Casola, and R. G. Pestell Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8 PNAS, May 13, 2008; 105(19): 6924 - 6929. [Abstract] [Full Text] [PDF]

				A. K. Nath, R. M. Brown, M. Michaud, M. R. Sierra-Honigmann, M. Snyder, and J. A. Madri Leptin affects endocardial cushion formation by modulating EMT and migration via Akt signaling cascades J. Cell Biol., April 21, 2008; 181(2): 367 - 380. [Abstract] [Full Text] [PDF]

				M. L. Gruen, M. Hao, D. W. Piston, and A. H. Hasty Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1481 - C1488. [Abstract] [Full Text] [PDF]

				A. Hamik, B. Wang, and M. K. Jain Transcriptional Regulators of Angiogenesis Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1936 - 1947. [Abstract] [Full Text] [PDF]

				K. Y. Kim and H. G. Cheon Antiangiogenic Effect of Rosiglitazone Is Mediated via Peroxisome Proliferator-activated Receptor {gamma}-activated Maxi-K Channel Opening in Human Umbilical Vein Endothelial Cells J. Biol. Chem., May 12, 2006; 281(19): 13503 - 13512. [Abstract] [Full Text] [PDF]

				H. S. Elbatarny and D. H. Maurice Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E695 - E702. [Abstract] [Full Text] [PDF]

				L. Li, J.-C. Mamputu, N. Wiernsperger, and G. Renier Signaling Pathways Involved in Human Vascular Smooth Muscle Cell Proliferation and Matrix Metalloproteinase-2 Expression Induced by Leptin: Inhibitory Effect of Metformin Diabetes, July 1, 2005; 54(7): 2227 - 2234. [Abstract] [Full Text] [PDF]

				P. L. Huang Unraveling the Links Between Diabetes, Obesity, and Cardiovascular Disease Circ. Res., June 10, 2005; 96(11): 1129 - 1131. [Full Text] [PDF]

				D. C. W. Lau, B. Dhillon, H. Yan, P. E. Szmitko, and S. Verma Adipokines: molecular links between obesity and atheroslcerosis Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2031 - H2041. [Abstract] [Full Text] [PDF]

				S. Han, H. N. Rivera, and J. Roman Peroxisome Proliferator-Activated Receptor-{gamma} Ligands Inhibit {alpha}5 Integrin Gene Transcription in Non-Small Cell Lung Carcinoma Cells Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 350 - 359. [Abstract] [Full Text] [PDF]

				A Galli, E Ceni, D W Crabb, T Mello, R Salzano, C Grappone, S Milani, E Surrenti, C Surrenti, and A Casini Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPAR{gamma} independent mechanisms Gut, November 1, 2004; 53(11): 1688 - 1697. [Abstract] [Full Text] [PDF]

				H. Huang, S. C. Campbell, D. F. Bedford, T. Nelius, D. Veliceasa, E. H. Shroff, J. Henkin, A. Schneider, N. Bouck, and O. V. Volpert Peroxisome Proliferator-Activated Receptor {gamma} Ligands Improve the Antitumor Efficacy of Thrombospondin Peptide ABT510 Mol. Cancer Res., October 1, 2004; 2(10): 541 - 550. [Abstract] [Full Text] [PDF]

				G. J. Hausman and R. L. Richardson Adipose tissue angiogenesis J Anim Sci, March 1, 2004; 82(3): 925 - 934. [Abstract] [Full Text] [PDF]

				B. Stiles, Y. Wang, A. Stahl, S. Bassilian, W. P. Lee, Y.-J. Kim, R. Sherwin, S. Devaskar, R. Lesche, M. A. Magnuson, et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity PNAS, February 17, 2004; 101(7): 2082 - 2087. [Abstract] [Full Text] [PDF]

				G. Boguslawski, P. W. McGlynn, K. A. Harvey, and A. T. Kovala SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Causes Accumulation of Phosphorylated ERK Kinases and Inhibits Their Activity in Vivo and in Vitro J. Biol. Chem., February 13, 2004; 279(7): 5716 - 5724. [Abstract] [Full Text] [PDF]

				M. P. Cleary, S. C. Juneja, F. C. Phillips, X. Hu, J. P. Grande, and N. J. Maihle Leptin Receptor-Deficient MMTV-TGF-{alpha}/LeprdbLeprdb Female Mice Do Not Develop Oncogene-Induced Mammary Tumors Experimental Biology and Medicine, February 1, 2004; 229(2): 182 - 193. [Abstract] [Full Text] [PDF]